Natural products and cancer: The urgent need to bridge the gap between preclinical and clinical research

doi:10.4251/wjgo.v17.i4.100484

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=0

Apr 15, 2025 (publication date) through Mar 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastrointest Oncol. Apr 15, 2025; 17(4): 100484
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.100484

Natural products and cancer: The urgent need to bridge the gap between preclinical and clinical research

Armando Rojas, Ileana González, Miguel Angel Morales

Armando Rojas, Ileana González, Biomedical Research Laboratories, Faculty of Medicine, Catholic University of Maule, Talca 34600000, Chile

Miguel Angel Morales, Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, University of Chile, Santiago 8320000, Chile

Author contributions: Rojas A, González I, and Morales MA, contributed to discussion and design of the manuscript, writing, and editing the manuscript, and review of literature; Rojas A, designed the overall concept and outline of the manuscript.

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Armando Rojas, PhD, Full Professor, Senior Researcher, Biomedical Research Laboratories, Faculty of Medicine, Catholic University of Maule, 3605 San Miguel Ave, Talca 34600000, Chile. arojasr@ucm.cl

Received: August 17, 2024
Revised: January 20, 2025
Accepted: January 27, 2025
Published online: April 15, 2025
Processing time: 219 Days and 19.4 Hours

Core Tip

Core Tip: Natural products have been extensively investigated for their anticancer potential for many decades, and some are milestones in the history of anticancer drug discovery. However, despite the compelling data achieved by preclinical studies, the challenges to validate the clinical use remain ahead.